Pivotal BioVenture Partners, an early investor in schizophrenia drug developer Karuna, vaccine maker Vaxcyte, raises second fund of $389 million - San Francisco Business Times
Pivotal Partner Giving Society | Partners
Pivotal Partners | LinkedIn
Pivotal | Services Microsoft Go-To-Market
The Pivotal Partners Group | LinkedIn
Pivotal Partners
Pivotal Healthcare Partners Overview | SignalHire Company Profile
Pivotal Partners - Crunchbase Company Profile & Funding
Pivotal Fitness - Corporate Partnerships | It's All Here